High Tide Inc. (HITI)

NASDAQ: HITI · Real-Time Price · USD

2.310

-0.060 (-2.53%)

At close: Jun 18, 2026, 4:00 PM EDT

2.330

+0.020 (0.87%)

After-hours: Jun 18, 2026, 7:55 PM EDT

-2.53% (1D)

Market Cap	205.77M +9.1%
Revenue (ttm)	493.19M +22.0%
Net Income	-32.35M
EPS	-0.38
Shares Out	87.87M
PE Ratio	n/a
Forward PE	27.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	612,252
Open	2.370
Previous Close	2.370
Day's Range	2.300 - 2.390
52-Week Range	2.120 - 4.055
Beta	1.03
Analysts	Strong Buy
Price Target	5.67 (+145.46%)
Earnings Date	Jun 15, 2026

About HITI

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Bricks and Mortar, E-commerce, and Medical Cannabis Distribution segments. It manufactures and distributes consumption accessories; cannabis; and hemp derived products. The company also engages in data analytics; advertising; product sourcing and imports; event-based cannabis retail; medical cannabis distribution; accessories retail; and other related services. It provides its products under the Daily High Club,... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 2009

Employees 1,832

Stock Exchange NASDAQ

Ticker Symbol HITI

Website https://www.hightideinc.com

Full Company Profile

Financial Performance

In fiscal year 2025, High Tide's revenue was 593.99 million, an increase of 13.72% compared to the previous year's 522.31 million. Losses were -50.75 million, 1070.1% more than in 2024.

Financial numbers in CAD Financial Statements

Analyst Summary

According to 6 analysts, the average rating for HITI stock is "Strong Buy." The 12-month stock price target is $5.67, which is an increase of 145.46% from the latest price.

Price Target

$5.67

(145.46% upside)

Analyst Consensus: Strong Buy

Stock Forecasts

News

High Tide Transcript: Planet MicroCap Las Vegas 2026

Expanded to 228 stores with a leading loyalty program and 161% same-store sales growth since 2021. Discount club model, operational efficiency, and strategic real estate drive profitability and market share gains in Canada and Germany. Free cash flow positive and poised for further expansion.

2 days ago - Transcripts

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

CALGARY, AB, June 17, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world ...

2 days ago - PRNewsWire

High Tide Earnings Call Transcript: Q2 2026

Q2 2026 delivered record revenue, gross profit, and adjusted EBITDA, driven by strong Canadian retail and rapid growth in Germany. Market share gains, disciplined M&A, and a new CAD 40 million credit facility position the company for further expansion.

3 days ago - Transcripts

High Tide Earnings release: Q2 2026

High Tide released its Q2 2026 earnings on June 16, 2026, summarizing the period's financial results.

3 days ago - Filings

High Tide Earnings release: Q2 2026

High Tide released its Q2 2026 earnings on June 16, 2026, summarizing the period's financial results.

3 days ago - Filings